Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSTC1 in Diabetic Foot Ulcers
NCT01813305Phase 2Completed
- Sponsor
- Charsire Biotechnology
- Start
- Jul 2014
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing CSTC1 with Vehicle (2 arms). Primary endpoint: Number of Participants With Complete Ulcer Closure During the Treatment Period at 14 weeks. Started Jul 2014; status: completed.
02
Drugs
CSTC1
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01813305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813305.